Skip to content
GILDGilead Sciences Inc.

GILD Earnings

Gilead Sciences Inc. next reports earnings on October 29, 2026. Track record: 4/4 beats.

Next Earnings In

43Days
:
20Hours
:
40Min
:
28Sec

Thursday, October 29, 2026

Current Price

$146.30

EPS Estimate

Earnings Per Share

$2.15

-13.1% YoY

Trailing EPS

Last 12 months earnings

-$2.65

Beat Rate

4/4

100%

Forward P/E

Price-to-Earnings ratio

14.8

Margin: -10.6%

Analyst Rating

Buy

27 analysts

Analyst Sentiment

Buy27 analysts
Target: $158.15+8.1%Full analysis →

Earnings History

4/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-06-30-$7.25-$6.75+6.9%Beat
2026-03-31$1.91$2.03+6.2%Beat
2025-12-31$1.81$1.86+2.8%Beat
2025-09-30$2.14$2.47+15.7%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$2.15-13.1%
Next Qtr(+1q)$2.19+17.7%
Current Year(0y)-$0.43-105.2%
Next Year(+1y)$9.89+2419.9%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$2.15

Revenue Estimate

$7.8B

Annual EPS Est.

-$0.43

-105.2% YoY

GILD Earnings FAQ

When is GILD's next earnings date?

Gilead Sciences Inc. (GILD) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $2.15.

Does GILD usually beat earnings estimates?

Gilead Sciences Inc. has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).

What is GILD's trailing EPS?

Gilead Sciences Inc.'s trailing twelve-month EPS is -$2.65. This is calculated from the last four quarters of reported earnings.

What do analysts think about GILD?

27 Wall Street analysts cover Gilead Sciences Inc.. The consensus rating is "Buy" with an average price target of $158.15, implying 8.1% upside from the current price.